HMPL-506

Phase 1Recruiting
0 watching 0 views this week๐Ÿ’ค Quiet
28
Hype Score

Development Stage

โœ“
Pre-clinical
2
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Hematological Malignancies

Conditions

Hematological Malignancies

Trial Timeline

May 27, 2024 โ†’ Dec 8, 2027

About HMPL-506

HMPL-506 is a phase 1 stage product being developed by HUTCHMED for Hematological Malignancies. The current trial status is recruiting. This product is registered under clinical trial identifier NCT06387082. Target conditions include Hematological Malignancies.

Hype Score Breakdown

Clinical
10
Activity
5
Company
5
Novelty
3
Community
2

Clinical Trials (1)

NCT IDPhaseStatus
NCT06387082Phase 1Recruiting